The report "Cardiovascular Ultrasound Market by Technology (2D, 3D/4D, Doppler), Type ((Trans-Thoracic, Trans-Esophageal, Stress Echocardiogram), Fetal Ultrasound), Display (Color, B/W), End User (Hospitals, Diagnostic Centers, ASCS, Home Care) - Global Forecasts to 2030", cardiovascular ultrasound market is projected to reach USD 2.95 billion by 2030 from USD 1.56 billion in 2022, at a CAGR of 6.5% during the forecast period
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cardiovascular-ultrasound-Market-2792974.html
Factors such as the rising geriatric population more prone to develop cardiovascular diseases and growing awareness for early disease diagnosis are the key factors supporting the market growth. Moreover, rapid technological advancements and increasing product development initiatives from public/private organizations are further expected to support market growth.
Based on technology, the 3D/4D ultrasound segment registered the highest growth over the forecast period
The cardiovascular ultrasound market is segmented on technology into 2D, 3D/4D, and doppler ultrasound. The 3D/4D ultrasound segment registers the highest growth over the forecast period, owing to advantages offered by the technology, such as greater diagnostic accuracy, operational maneuverability, and cross-sectional imaging capabilities. Moreover, technological advancement & new product launches will further drive the segment growth.
North America to command the largest share of the cardiovascular ultrasound market in 2022
Based on region, the cardiovascular ultrasound market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to account for the largest share of the cardiovascular ultrasound market in 2022. The growth of the North American market is primarily driven by the high prevalence of cardiovascular diseases, rapid adoption of technologically advanced imaging modalities, significant healthcare expenditure, and well-established regional players.
As of 2022, the prominent players in the cardiovascular ultrasound market include GE Healthcare (US), Hitachi Corporation (Japan), Samsung (South Korea), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Chison Medical Technologies (China), Clarius Mobile Health (Canada), Esaote (Italy), Ricso Technology (Israel), and SIUI (China), among others.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com